Combining an anti‐CD47 antibody with rituximab resulted in enhanced phagocytosis of NHL cells in vitro and synergistic antitumor activity in NHL‐engrafted mice in vivo.18 Here, CD47 is linked to non-Hodgkin lymphoma.